Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
2,181,288,547
-
Number of holders
-
1,369
-
Total 13F shares, excl. options
-
133,423,708
-
Shares change
-
-4,323,807
-
Total reported value, excl. options
-
$16,144,171,651
-
Value change
-
-$490,795,407
-
Put/Call ratio
-
100%
-
Number of buys
-
589
-
Number of sells
-
549
-
Price
-
$121.01
Institutional Holders of NOVARTIS AG - Ordinary Shares (NVS) as of Q2 2025
As of 30 Jun 2025 NOVARTIS AG - Ordinary Shares (NVS) had 1,369 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 133,423,708 shares of stock of the company.
Largest 10 holders included Dodge & Cox, PRIMECAP MANAGEMENT CO/CA/, DIMENSIONAL FUND ADVISORS LP, MORGAN STANLEY, Fisher Asset Management, LLC, LOOMIS SAYLES & CO L P, BANK OF AMERICA CORP /DE/, FRANKLIN RESOURCES INC, GOLDMAN SACHS GROUP INC, and WELLINGTON MANAGEMENT GROUP LLP.
This table shows 1,370 institutional shareholders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.